AIP
NEOS

Ameritas Investment Partners’s Neos Therapeutics, Inc NEOS Stock Holding History

Ameritas Investment Partners’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,051
Closed -$5K – 3151
2019
Q1 		$5K Hold
2,051
– – ﹤0.01% 2871
2018
Q4 		$3K Hold
2,051
– – ﹤0.01% 2930
2018
Q3 		$10K Hold
2,051
– – ﹤0.01% 2844
2018
Q2 		$13K Hold
2,051
– – ﹤0.01% 2760
2018
Q1 		$17K Hold
2,051
– – ﹤0.01% 2511
2017
Q4 		$21K Buy
2,051
+980
+92% +$9.4K ﹤0.01% 2420
2017
Q3 		$8K Hold
1,071
– – ﹤0.01% 2855
2017
Q2 		$8K Hold
1,071
– – ﹤0.01% 2882
2017
Q1 		$8K Buy
+1,071
New +$6.64K ﹤0.01% 2767

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Partners's NEOS Position: Q2 2019 in Review

Ameritas Investment Partners sold out of Neos Therapeutics, Inc (NEOS) in Q2 2019, closing a stake of 2,051 shares — an estimated $5K sold.

Ameritas Investment Partners first reported a position in NEOS in Q1 2017 and held it in 9 quarters. The position peaked at $21K in Q4 2017. 58 funds tracked by Wall St. Rank hold NEOS as of Q2 2019.

  • Ameritas Investment Partners reported no remaining Neos Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,051 Neos Therapeutics, Inc shares in Q2 2019, an estimated $5K.
  • Ameritas Investment Partners first reported a position in Neos Therapeutics, Inc in Q1 2017 and held it in 9 quarters.
  • Ameritas Investment Partners's Neos Therapeutics, Inc position peaked at $21K in Q4 2017.
  • 58 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.